Pulmonx Corporation (LUNG) Financials

LUNG Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 120.0 million 74.2 million
Dec. 31, 2025 129.3 million 75.2 million
Sept. 30, 2025 138.3 million 78.2 million
June 30, 2025 147.2 million 78.1 million

LUNG Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -10.1 million 4.1 million
Dec. 31, 2025 -7.1 million 4.2 million
Sept. 30, 2025 -8.3 million 5.2 million
June 30, 2025 -4.0 million 6.2 million

LUNG Net Income

No data available :(

LUNG Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 61.6 million 55.0 million 19.0 million
Dec. 31, 2025 70.0 million 37.0 million 18.1 million
Sept. 30, 2025 76.5 million 37.0 million 19.4 million
June 30, 2025 84.2 million 37.0 million 19.7 million

LUNG Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 41.9 million
Dec. 31, 2025 41.4 million
Sept. 30, 2025 40.9 million
June 30, 2025 40.2 million

LUNG Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 9000 4.9 million 24.1 million -
Dec. 31, 2025 13000 4.6 million 22.9 million -
Sept. 30, 2025 89000 4.8 million 25.6 million -
June 30, 2025 48999 5.3 million 26.7 million -

LUNG Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 20.6 million 4.5 million
Dec. 31, 2025 22.6 million 5.1 million
Sept. 30, 2025 21.5 million 5.5 million
June 30, 2025 23.9 million 6.7 million

LUNG

Price: $1.28

52 week price:
1.13
3.88

Earnings Per Share: -1.30 USD

Exchange: NMS

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 23949

Market Capitalization: 68.4 million

Links: